Metabolome Analysis in Patients With Rheumatoid Arthritis
Overview
The aim of this study is to investigate discriminant metabolites in urine from patients with rheumatoid arthritis (RA) from healthy individuals. Then we determine if the patient's metabolic fingerprint could predict the development or flare-up of RA.
Study Type
- Study Type: Observational [Patient Registry]
- Study Design
- Time Perspective: Cross-Sectional
- Study Primary Completion Date: October 2018
Detailed Description
Compare metabolites between RA patients and healthy individuals. 1. Collection urine sample 2. Assessing urine metabolites by 1H NMR spectroscopy 3. Analyzing the relationships between metabolites and clinical variables
Clinical Trial Outcome Measures
Primary Measures
- Metabolic fingerprint of rheumatoid arthritis
- Time Frame: 1 years
- Metabolomic analyses of urine from patients with rheumatoid arthritis, healthy controls and other autoimmune disease
Secondary Measures
- Correlations between specific metabolites and disease activity/severity of RA
- Time Frame: 1 year
- Identified metabolites and their clinical significances
Participating in This Clinical Trial
Inclusion Criteria
- All patients with rheumatoid arthritis meet 2010 American College of Rheumatology/European League against Rheumatism classification criteria. Exclusion Criteria:
- Comorbid with other autoimmune diseases – Confirmed with amyloidosis – Chronic kidney disease (estimated GFR < 60 ml/min/1.73m2) – Chronic liver disease – Thyroid disease – Pregnancy – Solid tumor/hematologic malignancy within 5 years
Gender Eligibility: All
Minimum Age: 18 Years
Maximum Age: N/A
Are Healthy Volunteers Accepted: Accepts Healthy Volunteers
Investigator Details
- Lead Sponsor
- The Catholic University of Korea
- Provider of Information About this Clinical Study
- Principal Investigator: Jung Hee Koh, MD – The Catholic University of Korea
- Overall Official(s)
- Jung Hee Koh, MD, Principal Investigator, Seoul St.Mary’s hospital, The Catholic university of Korea
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.